Hantz Financial Services, Inc. Repligen Corp Transaction History

Hantz Financial Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 06, 2024	SELL	$170.78 - $208.42 $170 - $208	-1 Reduced 10.0%	9 $2,000
Q3 2023 Aug 06, 2024	SELL	$138.78 - $176.51 $11,935 - $15,179	-86 Reduced 89.58%	10 $2,000
Q2 2022 Aug 06, 2024	SELL	$140.68 - $188.02 $621,664 - $830,860	-4,419 Reduced 97.87%	96 $16,000
Q1 2022 Aug 06, 2024	BUY	$161.19 - $257.96 $217,767 - $348,503	1,351 Added 42.7%	4,515 $849,000
Q4 2021 Aug 06, 2024	BUY	$247.59 - $304.47 $215,403 - $264,888	870 Added 37.93%	3,164 $838,000
Q3 2021 Aug 06, 2024	BUY	$194.77 - $324.21 $446,802 - $743,737	2,294 New	2,294 $663,000

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.36B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.